Victory Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Victory Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-63,471	Closed	-$3.35M	–	2546
2026 Q1	$3.35M	Buy	63,471 +54,707	+624%	+$2.25M	﹤0.01%	1459
2025 Q4	$354K	Buy	+8,764	New	+$203K	﹤0.01%	2090
2023 Q3	–	Sell	-73,930	Closed	-$647K	–	2556
2023 Q2	$647K	Buy	+73,930	New	+$862K	﹤0.01%	1880

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Victory Capital Management's TERN Position: Q2 2026 in Review

Victory Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 63,471 shares — an estimated $3.35M sold.

Victory Capital Management first reported a position in TERN in Q2 2023 and held it in 3 quarters. The position peaked at $3.35M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Victory Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Victory Capital Management sold 63,471 Terns Pharmaceuticals shares in Q2 2026, an estimated $3.35M.
Victory Capital Management first reported a position in Terns Pharmaceuticals in Q2 2023 and held it in 3 quarters.
Victory Capital Management's Terns Pharmaceuticals position peaked at $3.35M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.